首頁
Reata Pharmaceuticals, Inc.

11月 2025Reata Pharmaceuticals, Inc.的市場佔有率分析

biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

健康 > 生物技術和製藥

域名reatapharma.com

成立年份2002

僱員201 - 500

年度營收$15M - $25M

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.（包含公司地區）

reatapharma.com

查看更多網站流量與參與度資訊

Reata Pharmaceuticals, Inc.截至 11月 2025 的總收入為 15M - 25M

Reata Pharmaceuticals, Inc. 熱門網域產生的總收入

Reata Pharmaceuticals, Inc. 熱門網域 3 年內的總收入

Reata Pharmaceuticals, Inc. 熱門網域的總收入

reatapharma.com15M - 25M

透過銷售情報查看更多內容

Reata Pharmaceuticals, Inc.的熱門網域總造訪量

了解Reata Pharmaceuticals, Inc.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Reata Pharmaceuticals, Inc.的熱門網域平均造訪時長

分析Reata Pharmaceuticals, Inc.參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Reata Pharmaceuticals, Inc.的熱門網域平均頁面瀏覽量

了解Reata Pharmaceuticals, Inc.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Reata Pharmaceuticals, Inc.按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

phadia.com公司名Phadia僱員5001 - 10000總部瑞典, Uppsala年度營收$200M - $500M訪問總量2.5K健康 > 生物技術和製藥

使用的熱門技術Reata Pharmaceuticals, Inc.

这些是Reata Pharmaceuticals, Inc.顶级域名使用的行业网站技术

轉換與分析 (4)

Google Analytics

電子郵件服務 (4)

Sendgrid

社群 (4)

Instagram

小工具 (4)

Twemoji

更多技術

9

檢視所有

新聞與訊號來自Reata Pharmaceuticals, Inc.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Manmeet leaves Reata Pharmaceuticals, Inc. as President, Chief Operating Officer and Chief Financial Officer.Manmeet joins us from Reata Pharmaceuticals, where he was the President, Chief Operating Officer and Chief Financial Officer.

新聞Soni leaves Reata Pharmaceuticals, Inc. as President, Chief Operating Officer, & Chief Financial Officer.Mr. Soni has over 20 years of financial and operational leadership experience and joins Summit from Reata Pharmaceuticals, Inc., where he was President, Chief Operating Officer, & Chief Financial Officer.

新聞Reata Pharmaceuticals, Inc. decreased headcount by 113 on Sep 12th '23.In a recent Worker Adjustment and Retraining Notification (WARN) notice sent to state officials in Texas, Reata said it's cutting 113 positions.